Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.

De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Del Favero J, Rantalainen M, Rajan P, Sleijfer S, Ullén A, Yachnin J, Grönberg H, Van Laere SJ, Lindberg J, Dirix LY.

Clin Cancer Res. 2018 Sep 12. pii: clincanres.1943.2018. doi: 10.1158/1078-0432.CCR-18-1943. [Epub ahead of print]

PMID:
30209161
2.

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff I, van Dam V, Brouwer A, van Dam PJ, Van den Eynden G, Rutten A, Sleijfer S, Vandebroek J, Van Laere S, Dirix L.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.

PMID:
29431193
3.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW.

Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.

PMID:
26947523
4.

Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?

van Dam PA, van Dam VC, Altintas S, Papadimitriou K, Rolfo C, Trinh XB.

Eur J Surg Oncol. 2016 Mar;42(3):333-42. doi: 10.1016/j.ejso.2015.10.015. Epub 2015 Nov 23. Review.

PMID:
26776766
5.

Lipidation of the autotransporter NalP of Neisseria meningitidis is required for its function in the release of cell-surface-exposed proteins.

Roussel-Jazédé V, Grijpstra J, van Dam V, Tommassen J, van Ulsen P.

Microbiology. 2013 Feb;159(Pt 2):286-95. doi: 10.1099/mic.0.063982-0. Epub 2012 Dec 20.

PMID:
23258267
6.

Generating knock-out and complementation strains of Neisseria meningitidis.

van Dam V, Bos MP.

Methods Mol Biol. 2012;799:55-72. doi: 10.1007/978-1-61779-346-2_4.

PMID:
21993639
7.

Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane.

Mohammadi T, van Dam V, Sijbrandi R, Vernet T, Zapun A, Bouhss A, Diepeveen-de Bruin M, Nguyen-Distèche M, de Kruijff B, Breukink E.

EMBO J. 2011 Apr 20;30(8):1425-32. doi: 10.1038/emboj.2011.61. Epub 2011 Mar 8.

8.

Patients' perceptions of doctors' clothing: should we really be 'bare below the elbow'?

Bond L, Clamp PJ, Gray K, Van Dam V.

J Laryngol Otol. 2010 Sep;124(9):963-6. doi: 10.1017/S0022215110001167. Epub 2010 Jun 2.

PMID:
20519044
9.

Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies.

van Dam V, Olrichs N, Breukink E.

Chembiochem. 2009 Mar 2;10(4):617-24. doi: 10.1002/cbic.200800678. Review.

PMID:
19173317
10.

Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.

de Kruijff B, van Dam V, Breukink E.

Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):117-21. doi: 10.1016/j.plefa.2008.09.020. Epub 2008 Nov 12. Review.

PMID:
19008088
11.

Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies.

Ten Boekel E, Siegert CE, Vrielink GJ, Van Dam VC, Ceelen A, De Kieviet W.

J Clin Immunol. 2007 Sep;27(5):467-76. Epub 2007 Jul 18. Erratum in: J Clin Immunol. 2008 Jan;28(1):93.

12.

Transmembrane transport of peptidoglycan precursors across model and bacterial membranes.

van Dam V, Sijbrandi R, Kol M, Swiezewska E, de Kruijff B, Breukink E.

Mol Microbiol. 2007 May;64(4):1105-14.

Supplemental Content

Loading ...
Support Center